5-(3-(Trifluoromethyl)benzylidene)thiazolidine-2,4-dione

Catalog No. :
ACJFWM162
CAS No. :
327033-36-3
Molecular Formula :
C11H6F3NO2S
Molecular Weight :
273.23

IUPAC Name:(E)-5-(3-(trifluoromethyl)benzylidene)thiazolidine-2,4-dione

5-(3-(Trifluoromethyl)benzylidene)thiazolidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$68.00Login to see priceInquiryInquiry
50mg98%$115.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(3-(Trifluoromethyl)benzylidene)thiazolidine-2,4-dione
IUPAC Name(E)-5-(3-(trifluoromethyl)benzylidene)thiazolidine-2,4-dione
MDL No.MFCD01207145
Molecular FormulaC11H6F3NO2S
Molecular Weight273.23
SMILESO=C(NC/1=O)SC1=C\C2=CC=CC(C(F)(F)F)=C2
InChI KeyNGJLOFCOEOHFKQ-VMPITWQZSA-N
Synonym5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione;SMI-4a ≥95%(NMR);CS-627;SMI-4q;SMI-4a5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione;2,4-Thiazolidinedione, 5-[[3-(trifluoromethyl)phenyl]methylene]-;2 Kinase Inhibitor V;5-(3-(Trifluoromethyl)benzylidene)thiazolidine-2,4-dione
CAS No.327033-36-3
PubChem CID1361332

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJFWM162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOFNI502 route compound structure diagram
    ACOFNI5022295-31-0 In Stock
  2. Plus
  3. ACRHNA746 route compound structure diagram
    ACRHNA746454-89-7 In Stock
  4. Then
  5. ACJFWM162 route product structure diagram
    ACJFWM162327033-36-3
Inquiry

2. ACJFWM162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJFWM162 route product structure diagram
    ACJFWM162327033-36-3
Inquiry

Comments (0)